Related Experiment Video
Updated: Jan 31, 2026

The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
PIK3CA Mutations Downregulate PPT1 to Promote Adipogenesis by Suppressing P300 Depalmitoylation and Phase Separation
Hongrui Chen1,2, Zening Huang3, Rui Chang1
1Department of Plastic & Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
PIK3CA mutations drive benign adipose overgrowth in facial infiltrating lipomatosis (FIL), but the downstream molecular mechanisms remain incompletely understood. This study investigated the role of palmitoyl-protein thioesterase 1 (PPT1)-mediated depalmitoylation in regulating aberrant adipogenesis induced by mutant PIK3CA. Using single-cell RNA-seq, molecular dynamics simulations, and functional assays in primary human FIL adipose-derived stem and progenitor cells (ASPCs), immortalized cell lines, and mouse models, we dissected the signaling pathway linking PIK3CA mutation to adipogenesis. Techniques included ChIP-qPCR, acyl-biotin exchange assays, luciferase reporter assays, and RNA/ATAC sequencing. PIK3CA mutations transcriptionally repressed PPT1 via PI3K-AKT-c-JUN signaling. Downregulated PPT1 enhanced palmitoylation of the transcriptional coactivator P300 at C1176. This modification stabilized P300 by impairing its interaction with HSC70 and subsequent chaperone-mediated lysosomal degradation. Furthermore, C1176 palmitoylation inhibited P300 phase separation, thereby preserving its histone acetyltransferase activity. Sustained P300 activity promoted chromatin accessibility and expression of adipogenic genes, driving excessive adipogenesis in FIL. These findings established a novel "palmitoylation-phase separation-epigenetic regulation" axis in cellular fate determination and revealed PPT1 and P300 as potential therapeutic targets for FIL.
Insights
PIK3CA mutations in facial infiltrating lipomatosis (FIL) disrupt PPT1 depalmitoylation, stabilizing P300. This drives excessive adipogenesis, offering new therapeutic targets for FIL.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Facial infiltrating lipomatosis (FIL) is driven by PIK3CA mutations, but the underlying molecular pathways are not fully understood.
- Aberrant adipogenesis is a hallmark of FIL, leading to benign adipose overgrowth.
- Understanding the regulation of adipogenesis in FIL is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the role of palmitoyl-protein thioesterase 1 (PPT1) in regulating adipogenesis driven by PIK3CA mutations in FIL.
- To elucidate the molecular mechanisms by which PPT1 influences adipogenic gene expression and cellular fate.
- To identify potential therapeutic targets for FIL based on the discovered signaling pathway.
Main Methods:
- Single-cell RNA-seq, molecular dynamics simulations, and functional assays in human FIL cells and mouse models.
- Chromatin immunoprecipitation (ChIP-qPCR), acyl-biotin exchange assays, and luciferase reporter assays.
- RNA sequencing and ATAC sequencing to analyze gene expression and chromatin accessibility.
Main Results:
- PIK3CA mutations were found to transcriptionally repress PPT1 expression via the PI3K-AKT-c-JUN signaling pathway.
- Reduced PPT1 levels led to increased palmitoylation of the transcriptional coactivator P300 at C1176, stabilizing it.
- Palmitoylation of P300 preserved its histone acetyltransferase activity by inhibiting phase separation, promoting adipogenic gene expression and excessive adipogenesis in FIL.
Conclusions:
- A novel signaling axis involving "palmitoylation-phase separation-epigenetic regulation" controls cellular fate in FIL.
- PPT1 and P300 are key regulators of adipogenesis in FIL and represent potential therapeutic targets.
- This study provides critical insights into the molecular pathogenesis of FIL and opens avenues for novel treatment strategies.
More Related Videos
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
06:34In vitro Reconstitution of Cytoskeletal Networks inside Phase Separated Giant Unilamellar Vesicles (GUVs)
Published on: June 20, 2025
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Viral Mutations
The Eukaryotic Promoter Region
Phase Diagrams